Compare
Endovia Health Sciences, Inc. vs LQR House Inc. vs Innovation Beverage Group Ltd vs SRX Global Inc.
| Latest fiscal year | Endovia Health Sciences, Inc. EDVA | LQR House Inc. YHC | Innovation Beverage Group Ltd IBG | SRX Global Inc. SRXH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $73.1K | $1.56M | $2.77M | $6.53M |
| Revenue growth (YoY) | -90.9% | -37.4% | -5.1% | n/a |
| Gross margin | 23.1% | 10.8% | 44.2% | 23.4% |
| Operating margin | n/m | -730.3% | -194.2% | -174.6% |
| Net margin | n/m | n/m | -223.4% | -688.8% |
| Net income | -$25.23M | -$25.52M | -$6.19M | -$45.01M |
| EPS (Diluted) | -$11.97 | -$3.51 | -$13.09 | -$2.13 |
| Operating cash flow | -$4.82M | -$33.82M | -$1.56M | -$8.14M |
| Free cash flow | n/a | -$34.16M | -$1.57M | n/a |
| Cash & equivalents | $281.4K | n/a | $127.8K | $1.31M |
| Total assets | $965.7K | $31.23M | $1.29M | $8.40M |
| Total liabilities | $16.27M | $1.90M | $2.76M | $8.00M |
| Shareholders' equity | -$15.30M | $29.33M | -$1.47M | $407.0K |
| Return on year-end equity | n/a | -87.0% | n/a | n/m |
| Shares outstanding | 1.67M | 21.37M | 347.0K | 24.92M |
Revenue, most recent five fiscal years
| Fiscal year | Endovia Health Sciences, Inc. | LQR House Inc. | Innovation Beverage Group Ltd | SRX Global Inc. |
|---|---|---|---|---|
| Latest | $73.1K Ended 2025-12-31 | $1.56M Ended 2025-12-31 | $2.77M Ended 2025-12-31 | $6.53M Ended 2025-09-30 |
| 1 year earlier | $801.3K Ended 2024-12-31 | $2.50M Ended 2024-12-31 | $2.92M Ended 2024-12-31 | n/a |
| 2 years earlier | $18.85M Ended 2023-12-31 | $1.12M Ended 2023-12-31 | $3.15M Ended 2023-12-31 | n/a |
| 3 years earlier | $18.09M Ended 2022-12-31 | $601.1K Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | $11.32M Ended 2021-12-31 | n/a | n/a | n/a |